compounded semaglutide germantown (GLP-1) Compounded Semaglutide for Weight Loss

Meeting highlights from the PRAC 2326 October 2023: GLP-1 receptor agonists available evidence not supporting link with thyroid cancer

When you're ready to start GLP-1 therapy for weight loss or diabetes management, you face a important decision: should you work with an online doctor through a telehealth platform or visit a traditional endocrinologist in person

The approval represents Tevimbras first in the U.S

The FDA issued a warning letter on March 5 to Novo Nordisk after inspectors found the company had failed to properly report serious adverse events associated with Ozempic and Wegovy

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger

doi: 10.1172/JCI32601 57